QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☒ |
Smaller reporting company |
||||
Emerging growth company |
CHURCHILL CAPITAL CORP X
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025
TABLE OF CONTENTS
i
June 30, 2025 |
December 31, 2024 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Prepaid insurance |
||||||||
Total Current Assets |
||||||||
Deferred offering costs |
||||||||
Prepaid insurance- long term |
||||||||
Cash and marketable securities held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
IPO Promissory Note- |
||||||||
Total Current Liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A O rdinary S hares subject to possible redemption, and shares at redemption value of $per share and $ |
||||||||
Shareholders’ Deficit |
||||||||
Preference shares, $ |
||||||||
Class A O rdinary S hares, $ |
||||||||
Class B O rdinary S hares, $(1)(2) |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
Total Liabilities and Shareholders’ Deficit |
$ |
$ |
||||||
(1) | At December 31, 2024, included an aggregate of up to par value (the “Class B Ordinary Shares”), subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 5). On May 15, 2025, Churchill Capital Corp X (the “Company”) consummated its initial public offering and sold million units, which included the full exercise of the underwriters’ over-allotment option (the “Initial Public Offering”), hence the Class B Ordinary Shares are no longer subject to forfeiture. |
(2) | On February 15, 2024, Churchill Sponsor X LLC (the “Sponsor”) acquired an aggregate of Class B Ordinary Shares (the “Founder Shares”) for approximately $ per share. In April 2025, the Company effected a share capitalization in the form of a share dividend of approximately fully paid Class B Ordinary Shares for each Class B Ordinary Share in issue. In May 2025, the Company issued an additional Class B Ordinary Shares in a share capitalization, resulting in our Sponsor, holding an aggregate of Founder Shares. All share and per-share data have been retrospectively presented. |
Three Months Ended June 30, 2025 |
Three Months Ended June 30, 2024 |
Six Months Ended June 30, 2025 |
For the Period from January 4, 2024 (inception) through June 30, 2024 |
|||||||||||||
General and administrative costs |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
OTHER INCOME |
||||||||||||||||
Income earned on cash and marketable securities held in Trust Account |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income |
||||||||||||||||
NET INCOME (LOSS) |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic weighted average shares outstanding, Class A Ordinary Shares |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic net income per Class A ordinary share |
$ |
$ | $ |
$ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted weighted average shares outstanding, Class A Ordinary Shares |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted net income per Class A ordinary share |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic weighted average shares outstanding, Class B Ordinary Shares (1)(2) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic net income (loss) per Class B ordinary share |
$ |
$ | ( |
) | $ |
$ | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted weighted average shares outstanding, Class B Ordinary Shares (1)(2) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted net income (loss) per Class B ordinary share |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||
|
|
|
|
|
|
|
|
(1) | At December 31, 2024, included an aggregate of up to Class B Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 5). On May 15, 2025, the Company consummated its Initial Public Offering and sold million units, which included the full exercise of the underwriters’ over-allotment option, hence the Class B Ordinary Shares are no longer subject to forfeiture. |
(2) | On February 15, 2024, the Sponsor acquired an aggregate of Founder Shares for approximately $ per share. In April 2025, the Company effected a share capitalization in the form of a share dividend of approximately fully paid Class B Ordinary Shares for each Class B Ordinary Share in issue. In May 2025, the Company issued an additional Class B Ordinary Shares in a share capitalization, resulting in our Sponsor holding an aggregate of Founder Shares. All share and per-share data have been retrospectively presented. |
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — January 1, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2025 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
Accretion for Class A Ordinary Shares to redemption amount |
— |
— |
— |
— |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Sale of |
||||||||||||||||||||||||||||
Fair Value of Public Warrants at issuance |
— |
— |
— |
— |
||||||||||||||||||||||||
Allocated value of transaction costs to Class A Ordinary Shares |
— |
— |
— |
— |
( |
) | ( |
) | ||||||||||||||||||||
Fair value of Founder Share transfer or contributed |
— |
— |
— |
— |
||||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2025 (unaudited) |
$ |
$ |
$ | $ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — January 4, 2024 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Class B Ordinary Shares to Sponsor(1) (2) |
— | — | ||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2024 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2024 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Includes an aggregate of up to Class B Ordinary Shares, $ million Units, which includes the full exercise of the underwriters’ over-allotment option, hence the Class B Ordinary Shares are no longer subject to forfeiture. |
(2) | On February 15, 2024, the Sponsor acquired an aggregate of F ounder S hares for approximately $fully paid Class B Ordinary Shares for each Class B Ordinary Share in issue. In May 2025, the Company issued an additional Class B Ordinary Shares in a share capitalization, resulting in our Sponsor holding an aggregate of Founder Shares. All share and per-share data have been retrospectively presented. |
Six Months Ended June 30, 2025 |
For the Period from January 4, 2024 (inception) through June 30, 2024 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Payment of formation costs through issuance of Class B |
||||||||
Payment of operating costs through IPO Promissory Note |
||||||||
Income earned on cash and marketable securities held in Trust |
( |
) | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ||||||
Prepaid insurance |
( |
) | ||||||
Accrued expenses |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
||||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash into Trust Account |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) |
||||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Public Units |
||||||||
Proceeds from sale of Private Placement Units |
||||||||
Repayment of IPO Promissory Note—related party |
( |
) | ||||||
Payment of offering costs |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
Net Change in Cash |
||||||||
Cash – Beginning of year |
||||||||
|
|
|
|
|||||
Cash – End of period |
$ |
$ | ||||||
|
|
|
|
|||||
Supplemental disclosure of cash flow information: |
||||||||
Offering costs included in accrued offering costs |
$ | $ | ||||||
|
|
|
|
|||||
Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares |
$ | $ | ||||||
|
|
|
|
|||||
Deferred offering costs paid through IPO Promissory Note – related party |
$ | $ | ||||||
|
|
|
|
|||||
Prepaid services contributed by Sponsor through IPO Promissory Note—related party |
$ | $ | ||||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | $ | ||||||
|
|
|
|
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A Ordinary Shares issuance cost |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A Ordinary Shares subject to possible redemption, June 30, 2025 |
$ |
|||
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
For the period from January 4, 2024 (inception) through June 30, |
||||||||||||||||||||||||||||||
2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||||||||
Basic net income (loss) per share: |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Net income (loss) |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Basic weighted average shares outstanding |
||||||||||||||||||||||||||||||||
Basic net income (loss) per share |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
For the period from January 4, 2024 (inception) through June 30, |
||||||||||||||||||||||||||||||
2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||||||||
Diluted net income (loss) per share: |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Net income (loss) |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Diluted weighted average shares outstanding |
||||||||||||||||||||||||||||||||
Diluted net income (loss) per share |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||
May 13, 2025 |
||||
Restricted term (years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Discount for lack of marketability |
% |
• | In whole and not in part; |
• | At a price of $ per P W arrant; |
• | Upon not less than “30-day redemption period”); and |
• | if, and only if, the last sale price of the Class O rdinary S hares equals or exceeds $trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders. The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout such 30 trading day period and the |
Held to Maturity |
Level |
Amortized Cost |
Unrealized Gain (Loss) |
Fair Value |
||||||||||||||||
June 30, 2025 |
||||||||||||||||||||
U.S. Treasury Securities (Mature on 9/9/25 and 11/13/25) |
1 | $ | $ | ( |
) | $ |
May 15, 2025 |
||||
Market price of Public Shares |
$ | |||
Term (years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Likelihood of completing a business combination |
% |
June 30, 2025 |
December 31, 2024 |
|||||||
Trust Account |
$ |
$ |
||||||
Cash |
$ |
$ |
Three Months Ended June 30, 2025 |
Three Months Ended June 30, 2024 |
Six Months Ended June 30, 2025 |
For the Period from January 4, 2024 (inception) through June 30, 2024 |
|||||||||||||
General and administrative costs |
$ | $ | $ | $ | ||||||||||||
Income earned on marketable securities held in Trust Account |
$ | $ | $ | $ | ||||||||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this Quarterly Report on Form 10-Q (this “Report”) to “we,” “us” or the “Company” refer to Churchill Capital Corp X. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Churchill Sponsor X LLC, an affiliate of M. Klein and Company, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Report under Item 1. “Financial Statements”.
Overview
We are a blank check company incorporated in the Cayman Islands on January 4, 2024 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified. We intend to effectuate our initial Business Combination using cash derived from the proceeds of the Initial Public Offering consummated on May 15, 2025 and the sale of the Private Placement Units, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
We may seek to extend Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Memorandum and Articles of Association. Any such amendment would require the approval of the holders of our Public Shares, who will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account in which an amount of $414,000,000 from the net proceeds of the sale of the Public Units in the Initial Public Offering and the Private Placement Units in the Private Placement was placed following the closing of the Initial Public Offering and our capitalization, and may affect their ability to maintain our listing on Nasdaq Global Market (“Nasdaq”). In addition, the Nasdaq Rules currently require Special Purpose Acquisition Companies (“SPAC”) (such as us) to complete our initial Business Combination in accordance with the requirement by Nasdaq to complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement (the “Nasdaq 36-Month Requirement”). If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since January 4, 2024 (inception) through June 30, 2025, have been (i) organizational activities, those necessary and (ii) activities relating to the Initial Public Offering, described below, and (iii) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after the completion of our initial Business Combination. Subsequent to the Initial Public Offering, we have generated non-operating income in the form of interest income on investments held in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended June 30, 2025, we had a net income of $1,973,286, which consists of income earned on marketable securities held in the Trust Account of $2,158,518, partially offset by general and administrative costs of $185,232.
For the six months ended June 30, 2025, we had a net income of $1,955,086, which consists of income earned on marketable securities held in the Trust Account of $2,158,518, partially offset by general and administrative costs of $203,432.
For the three months ended June 30, 2024, we had a net loss of $7,230, which consisted of general and administrative costs.
For the period from January 4, 2024 (inception) through June 30, 2024, we had a net loss $51,841, which consisted of general and administrative costs.
Factors That May Adversely Affect our Results of Operations
Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our results of operations and our ability to complete an initial Business Combination could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. We cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our results of operations and our ability to complete an initial Business Combination.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B Ordinary Shares by the Sponsor and loans from the Sponsor.
On May 15, 2025, we consummated the Initial Public Offering of 41.4 million Public Units, each Public Unit consisting of one Class A Ordinary Share and one-fourth of one Public Warrant exercisable at an exercise price of $11.50 for one Class A Ordinary Share, which amount includes the full exercise of the underwriters’ over-allotment option of 5.4 million Public Units, generating gross proceeds of $414,000,000. Simultaneously, we consummated the sale of the Private Placement of 300,000 Private Placement Units for an aggregate of $3,000,000. Separately, an affiliate of BTIG, the representative of the underwriters for the Initial Public Offering, invested $500,000 in, and was admitted as a member of, the Sponsor in connection with the closing of the Initial Public Offering in exchange for interests in the Sponsor corresponding to 50,000 Private Placement Units and 200,000 Founder Shares.
16
Following the Initial Public Offering and the Private Placement, a total of $414,000,000 was placed in the Trust Account. We incurred $4,638,840 in offering expenses, consisting of $3,000,000 of deferred underwriting fee, and $1,638,840 of other offering costs.
For the six months ended June 30, 2025, cash used in operating activities was $757,617. Net income of $1,955,086 was affected by income earned on marketable securities held in the Trust Account of $2,158,518 and payment of operation costs through the IPO Promissory Note of $36,839. Changes in operating assets and liabilities used $591,024 of cash for operating activities.
For the period from January 4, 2024 (inception) through June 30, 2024, cash used in operating activities was $0. Net loss of $51,841 was affected by payment of formation costs through issuance of Class B Ordinary Shares of $4,827 and payment of operation costs through the IPO Promissory Note of $33,620. Changes in operating assets and liabilities provided $13,394 of cash for operating activities.
As of June 30, 2025, we had marketable securities held in the Trust Account of $416,158,518 consisting of U.S. government treasury obligations with maturity of 185 days or less or interests in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less permitted withdrawals), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2025, we had cash of $1,232,392. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, up to $1,500,000 of such loans may be convertible into units of the post business combination entity at a price of $10.00 per unit at the option of the lender. Such units and their underlying securities would be identical to the Private Placement Units. As of June 30, 2025 and December 31, 2024, the Company had no borrowings under any Working Capital Loans.
Additionally, to fund working capital, the Company has permitted withdrawals from the Trust Account available up to an annual limit of $1,000,000. These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the three and six months ended June 30, 2025, the Company has not withdrawn any amounts from the Trust Account for working capital purposes.
In connection with the Company’s assessment of going concern considerations in accordance with ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” as of June 30, 2025, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial statements. The Company cannot assure that its plans to consummate an initial Business Combination will be successful.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to reimburse the managing member of the Sponsor in an amount equal to $30,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
The underwriters are entitled to a Deferred Discount of up to $3,000,000 in the aggregate, payable only upon the Company’s completion of its initial Business Combination.
To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.
Critical Accounting Estimates
The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of June 30, 2025, we have identified the valuation of the Public Warrants at the Initial Public Offering and the BTIG Founder Shares as critical accounting estimates.
17
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our chief executive officer and chief financial officer (the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of June 30, 2025.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
Not applicable.
18
• | making our securities appear to be less attractive to potential target companies than the securities of an exchange listed SPAC; |
• | limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | the possibility that our Class A Ordinary Shares would be deemed “penny stock,” which will require brokers trading in our Class A Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | limited news and analyst coverage; and |
• | decreased ability to issue additional securities or obtain additional financing in the future. |
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Report on Form 10-Q.1
No. | Description of Exhibit | |
1.1 |
||
3.1 |
||
4.1 |
||
4.2 |
||
10.1 |
||
10.2 |
||
10.3 |
||
10.4 |
||
10.5 |
||
10.6 |
||
31.1* |
||
31.2* |
||
32.1** |
||
32.2** |
||
101.INS |
Inline XBRL Instance Document.* | |
101.SCH |
Inline XBRL Taxonomy Extension Schema Document.* | |
101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |
101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |
101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document.* | |
101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |
104 |
Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).* |
* |
Filed herewith. | |
** |
Furnished herewith. |
20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CHURCHILL CAPITAL CORP X | ||||||
Date: August 13, 2025 |
By: |
/s/ Michael Klein | ||||
Name: |
Michael Klein | |||||
Title: |
Chief Executive Officer, | |||||
(Principal Executive Officer) | ||||||
Date: August 13, 2025 |
By: |
/s/ Jay Taragin | ||||
Name: |
Jay Taragin | |||||
Title: |
Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
21